NCT00881673View on ClinicalTrials.gov

To Evaluate the Efficacy of AL-38583 in the Reduction of Tear Eosinophil Count Following Conjunctival Allergen Challenge

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

May 31, 2009

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2009

Conditions
Allergic Conjunctivitis
Interventions
DRUG

AL38583 Ophthalmic Solution

Topical ophthalmic

DRUG

Maxidex

Topical ophthalmic

DRUG

Vehicle

AL38583 Vehicle

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY

NCT00881673 - To Evaluate the Efficacy of AL-38583 in the Reduction of Tear Eosinophil Count Following Conjunctival Allergen Challenge | Biotech Hunter | Biotech Hunter